LCTX · Categories · Form 4
LCTX - SEC Form 4 insider transactions
Lineage Cell Therapeutics Inc. (LCTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for LCTX
- SEC Form 4 filed by President and CEO Culley Brian M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Howe Jill Ann4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by General Counsel and Secretary Samuel George A. Iii4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- General Counsel and Secretary Samuel George A. Iii converted options into 6,075 shares and covered exercise/tax liability with 2,502 shares, increasing direct ownership by 13% to 31,063 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- President and CEO Culley Brian M converted options into 31,250 shares and covered exercise/tax liability with 12,869 shares, increasing direct ownership by 8% to 240,516 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- President and CEO Culley Brian M was granted 8,925 shares and covered exercise/tax liability with 334 shares, increasing direct ownership by 4% to 222,135 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- General Counsel and Secretary Samuel George A. Iii was granted 1,735 shares and covered exercise/tax liability with 65 shares, increasing direct ownership by 6% to 27,490 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Bradsher Neal C4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Amin Dipti4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Jayasuriya Anula4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Andrews Deborah J4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Mulroy Michael H.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Russell Angus C.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by President and CEO Culley Brian M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Howe Jill Ann4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by General Counsel and Secretary Samuel George A. Iii4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- General Counsel Samuel George A. Iii converted options into 6,076 shares and covered exercise/tax liability with 2,440 shares, increasing direct ownership by 16% to 25,820 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- President and CEO Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,547 shares, increasing direct ownership by 10% to 213,544 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Mulroy Michael H.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Russell Angus C.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Andrews Deborah J4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Jayasuriya Anula4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Bailey Don M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Amin Dipti4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Director Bradsher Neal C4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Samuel George A. Iii4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Culley Brian M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Howe Jill Ann4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- Samuel George A. Iii covered exercise/tax liability with 2,490 shares and converted options into 6,076 shares, increasing direct ownership by 100% to 7,184 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,806 shares, increasing direct ownership by 15% to 144,842 units (SEC Form 4)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Bailey Don M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Mulroy Michael H.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Andrews Deborah J4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Russell Angus C.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Amin Dipti4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Kingsley Alfred D4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Jayasuriya Anula4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Bradsher Neal C4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Hogge Gary S.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Samuel George A. Iii4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Culley Brian M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Howe Jill Ann4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,744 shares, increasing direct ownership by 17% to 126,399 units to cover taxes4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Samuel George A. Iii converted options into 6,076 shares and covered exercise/tax liability with 2,478 shares to satisfy withholding tax4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Hogge Gary S. converted options into 13,020 shares and covered exercise/tax liability with 5,310 shares to satisfy tax liability4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Howe Jill Ann4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Mulroy Michael H.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Andrews Deborah J4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Russell Angus C.4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Amin Dipti4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Jayasuriya Anula4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Bradsher Neal C4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Bailey Don M4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4 filed by Kingsley Alfred D4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Culley Brian M converted options into 15,450 shares and covered exercise/tax liability with 5,343 shares, increasing direct ownership by 10% to 107,894 units to satisfy withholding obligation4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Culley Brian M converted options into 15,450 shares, covered exercise/tax liability with 5,343 shares and bought $9,792 worth of shares (6,400 units at $1.53), increasing direct ownership by 20% to 97,787 units to satisfy withholding obligation4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Amin Dipti bought $57,050 worth of shares (35,000 units at $1.63)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Culley Brian M bought $7,245 worth of shares (5,250 units at $1.38), increasing direct ownership by 7% to 81,280 units4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Broadwood Partners, L.P. bought $1,317,667 worth of shares (930,106 units at $1.42)4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
- SEC Form 4: Mulroy Michael H. bought $9,800 worth of shares (7,000 units at $1.40), increasing direct ownership by 3% to 258,555 units4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)